Corrigendum: Multidisciplinary Tinnitus Research: Challenges and Future Directions From the Perspective of Early Stage Researchers

Overview

Journal Front Aging Neurosci

Specialty Geriatrics

Date 2021 Aug 26

PMID 34434102

Citations 1

Authors

Jorge Piano Simoes

Elza Daoud

Maryam Shabbir

Sana Amanat

Kelly Assouly

Roshni Biswas

Chiara Casolani

Albi Dode

Falco Enzler

Laure Jacquemin

Mie Joergensen

Tori Kok

Nuwan Liyanage

Matheus Lourenco

Punitkumar Makani

Muntazir Mehdi

Anissa L Ramadhani

Constanze Riha

Jose Lopez Santacruz

Axel Schiller

Stefan Schoisswohl

Natalia Trpchevska

Eleni Genitsaridi

Affiliations

Soon will be listed here.

Abstract

[This corrects the article DOI: 10.3389/fnagi.2021.647285.].

Citing Articles

Current understanding of subjective tinnitus in adults.

Kang Y, Zheng Y Eur Arch Otorhinolaryngol. 2024; 281(9):4507-4517.

PMID: 38632112 DOI: 10.1007/s00405-024-08633-w.

References

Langguth B, Elgoyhen A, Cederroth C . Therapeutic Approaches to the Treatment of Tinnitus. Annu Rev Pharmacol Toxicol. 2018; 59:291-313. DOI: 10.1146/annurev-pharmtox-010818-021556. View

Israel J, Connelly J, McTigue S, BRUMMETT R, Brown J . Lidocaine in the treatment of tinnitus aurium. A double-blind study. Arch Otolaryngol. 1982; 108(8):471-3. DOI: 10.1001/archotol.1982.00790560009003. View

Trellakis S, Lautermann J, Lehnerdt G . Lidocaine: neurobiological targets and effects on the auditory system. Prog Brain Res. 2007; 166:303-22. DOI: 10.1016/S0079-6123(07)66028-2. View

Cederroth C, Dyhrfjeld-Johnsen J, Langguth B . An update: emerging drugs for tinnitus. Expert Opin Emerg Drugs. 2018; 23(4):251-260. DOI: 10.1080/14728214.2018.1555240. View

Hall D, Ray J, Watson J, Sharman A, Hutchison J, Harris P . A balanced randomised placebo controlled blinded phase IIa multi-centre study to investigate the efficacy and safety of AUT00063 versus placebo in subjective tinnitus: The QUIET-1 trial. Hear Res. 2019; 377:153-166. DOI: 10.1016/j.heares.2019.03.018. View

Gil-Gouveia R, Goadsby P . Neuropsychiatric side-effects of lidocaine: examples from the treatment of headache and a review. Cephalalgia. 2009; 29(5):496-508. DOI: 10.1111/j.1468-2982.2008.01800.x. View

Elgoyhen A, Langguth B . Pharmacological approaches to the treatment of tinnitus. Drug Discov Today. 2009; 15(7-8):300-5. DOI: 10.1016/j.drudis.2009.11.003. View

Hoekstra C, Rynja S, van Zanten G, Rovers M . Anticonvulsants for tinnitus. Cochrane Database Syst Rev. 2011; (7):CD007960. PMC: 6599822. DOI: 10.1002/14651858.CD007960.pub2. View

Schilder A, Su M, Blackshaw H, Lustig L, Staecker H, Lenarz T . Hearing Protection, Restoration, and Regeneration: An Overview of Emerging Therapeutics for Inner Ear and Central Hearing Disorders. Otol Neurotol. 2019; 40(5):559-570. DOI: 10.1097/MAO.0000000000002194. View

10.

Trellakis S, Benzenberg D, Urban B, Friederich P . Differential lidocaine sensitivity of human voltage-gated potassium channels relevant to the auditory system. Otol Neurotol. 2005; 27(1):117-23. DOI: 10.1097/01.mao.0000186443.11832.8a. View

11.

Wegner I, Hall D, Smit A, McFerran D, Stegeman I . Betahistine for tinnitus. Cochrane Database Syst Rev. 2019; 12:CD013093. PMC: 6433459. DOI: 10.1002/14651858.CD013093.pub2. View

12.

Van de Heyning P, Muehlmeier G, Cox T, Lisowska G, Maier H, Morawski K . Efficacy and safety of AM-101 in the treatment of acute inner ear tinnitus--a double-blind, randomized, placebo-controlled phase II study. Otol Neurotol. 2014; 35(4):589-97. PMC: 3966923. DOI: 10.1097/MAO.0000000000000268. View